Vir Biotechnology, Inc. (VIR) Presents at Morgan Stanley 23rd Annual Global Healthcare

PresentationMichael UlzEquity Analyst All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. And it's my pleasure to introduce the team from Vir Biotechnologies, including Marianne De Backer, CEO; as well as Mark Eisner, CMO. But before we get started, I just need to read a quick disclaimer for important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/re ...